+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Permanent Artificial Skin Market 2020-2024 - Product Image

Global Permanent Artificial Skin Market 2020-2024

  • ID: 5008950
  • Report
  • March 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Aroa Biosurgery Ltd.
  • AVITA Medical Ltd.
  • Mallinckrodt Plc
  • MiMedx Group Inc.
  • Misonix Inc.
  • Smith & Nephew Plc
  • MORE
Global Permanent Artificial Skin Market 2020-2024

The publisher has been monitoring the global permanent artificial skin market and it is poised to grow by USD 4.41 bn during 2020-2024, progressing at a CAGR of 19% during the forecast period. The report on the global permanent artificial skin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in R&D funding. In addition, availability of cost-effective treatment in developing countries is anticipated to boost the growth of the global permanent artificial skin market as well.

Market Segmentation

This global permanent artificial skin market is segmented as below:

End-User:
  • Hospitals
  • Other Healthcare Centers
Geographic Segmentation:
  • North America
  • Europe
  • APAC
  • ROW
Key Trends for global permanent artificial skin market growth

This study identifies availability of cost-effective treatment in developing countries as the prime reasons driving the global permanent artificial skin market growth during the next few years.

Prominent vendors in global permanent artificial skin market

The publisher provides a detailed analysis of around 25 vendors operating in the global permanent artificial skin market 2020-2024, including some of the vendors such as AVITA Medical Ltd., Aroa Biosurgery Ltd., Eucare Pharmaceuticals Pvt. Ltd., Integra LifeSciences Corp., Mallinckrodt Plc, MedSkin Solutions Dr. Suwelack AG, MiMedx Group Inc., Misonix Inc., Organogenesis Holdings Inc. and Smith & Nephew Plc .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aroa Biosurgery Ltd.
  • AVITA Medical Ltd.
  • Mallinckrodt Plc
  • MiMedx Group Inc.
  • Misonix Inc.
  • Smith & Nephew Plc
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
Drivers, Challenges, and Trends
  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AVITA Medical Ltd.
  • Aroa Biosurgery Ltd.
  • Eucare Pharmaceuticals Pvt. Ltd.
  • Integra LifeSciences Corp.
  • Mallinckrodt Plc
  • MedSkin Solutions Dr. Suwelack AG
  • MiMedx Group Inc.
  • Misonix Inc.
  • Organogenesis Holdings Inc.
  • Smith & Nephew Plc
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Market in focus
9. Parent market
12. Market characteristics
14. Offerings of vendors included in the market definition
16. Market segments
21. Global - Market size and forecast 2019 - 2024 ($ million)
22. Global market: Year-over-year growth 2019 - 2024 (%)
23. Five forces analysis 2019 & 2024
25. Bargaining power of buyers
26. Bargaining power of suppliers
27. Threat of new entrants
28. Threat of substitutes
29. Threat of rivalry
31. Market condition - Five forces 2019
32. Customer landscape
33. Market share by geography 2019-2024 (%)
34. Geographic comparison
36. North America - Market size and forecast 2019-2024 ($ million)
37. North America - Year-over-year growth 2019-2024 (%)
39. Europe - Market size and forecast 2019-2024 ($ million)
40. Europe - Year-over-year growth 2019-2024 (%)
42. APAC - Market size and forecast 2019-2024 ($ million)
43. APAC - Year-over-year growth 2019-2024 (%)
45. ROW - Market size and forecast 2019-2024 ($ million)
46. ROW - Year-over-year growth 2019-2024 (%)
47. Key leading countries
48. Market opportunity by geography ($ million)
49. Impact of drivers and challenges
50. Vendor landscape
52. Landscape disruption
54. Industry risk
56. Vendors covered
58. Market positioning of vendors
60. AVITA Medical Ltd. - Overview
61. AVITA Medical Ltd. - Business segments
62. AVITA Medical Ltd. - Key offerings
63. AVITA Medical Ltd. - Key customers
64. AVITA Medical Ltd. - Segment focus
66. Aroa Biosurgery Ltd. - Overview
67. Aroa Biosurgery Ltd. - Product and service
68. Aroa Biosurgery Ltd. - Key offerings
69. Aroa Biosurgery Ltd. - Key customers
70. Aroa Biosurgery Ltd. - Segment focus
72. Eucare Pharmaceuticals Pvt. Ltd. - Overview
73. Eucare Pharmaceuticals Pvt. Ltd. - Product and service
74. Eucare Pharmaceuticals Pvt. Ltd. - Key offerings
75. Eucare Pharmaceuticals Pvt. Ltd. - Key customers
76. Eucare Pharmaceuticals Pvt. Ltd. - Segment focus
78. Integra LifeSciences Corp. - Overview
79. Integra LifeSciences Corp. - Business segments
80. Integra LifeSciences Corp. - Key offerings
81. Integra LifeSciences Corp. - Key customers
82. Integra LifeSciences Corp. - Segment focus
84. Mallinckrodt Plc - Overview
85. Mallinckrodt Plc - Business segments
86. Mallinckrodt Plc - Key offerings
87. Mallinckrodt Plc - Key customers
88. Mallinckrodt Plc - Segment focus
90. MedSkin Solutions Dr. Suwelack AG - Overview
91. MedSkin Solutions Dr. Suwelack AG - Product and service
92. MedSkin Solutions Dr. Suwelack AG - Key offerings
93. MedSkin Solutions Dr. Suwelack AG - Key customers
94. MedSkin Solutions Dr. Suwelack AG - Segment focus
96. MiMedx Group Inc. - Overview
97. MiMedx Group Inc. - Business segments
98. MiMedx Group Inc. - Key offerings
99. MiMedx Group Inc. - Key customers
100. MiMedx Group Inc. - Segment focus
102. Misonix Inc. - Overview
103. Misonix Inc. - Business segments
104. Misonix Inc. - Key offerings
105. Misonix Inc. - Key customers
106. Misonix Inc. - Segment focus
108. Organogenesis Holdings Inc. - Overview
109. Organogenesis Holdings Inc. - Business segments
110. Organogenesis Holdings Inc. - Key offerings
111. Organogenesis Holdings Inc. - Key customers
112. Organogenesis Holdings Inc. - Segment focus
114. Smith & Nephew Plc - Overview
115. Smith & Nephew Plc - Business segments
116. Smith & Nephew Plc - Key offerings
117. Smith & Nephew Plc - Key customers
118. Smith & Nephew Plc - Segment focus
120. Currency conversion rates for US$
121. Research Methodology
122. Validation techniques employed for market sizing
123. Information sources
124. List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Aroa Biosurgery Ltd.
  • AVITA Medical Ltd.
  • Mallinckrodt Plc
  • MiMedx Group Inc.
  • Misonix Inc.
  • Smith & Nephew Plc
  • MORE
The publisher recognizes the following companies as the key players in the global permanent artificial skin market 2020-2024: AVITA Medical Ltd., Aroa Biosurgery Ltd., Eucare Pharmaceuticals Pvt. Ltd., Integra LifeSciences Corp., Mallinckrodt Plc, MedSkin Solutions Dr. Suwelack AG, MiMedx Group Inc., Misonix Inc., Organogenesis Holdings Inc. and Smith & Nephew Plc
.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the availability of cost-effective treatment in developing countries."

According to the report, one of the major drivers for this market is the increase in r&d funding.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • AVITA Medical Ltd.
  • Aroa Biosurgery Ltd.
  • Eucare Pharmaceuticals Pvt. Ltd.
  • Integra LifeSciences Corp.
  • Mallinckrodt Plc
  • MedSkin Solutions Dr. Suwelack AG
  • MiMedx Group Inc.
  • Misonix Inc.
  • Organogenesis Holdings Inc.
  • Smith & Nephew Plc
Note: Product cover images may vary from those shown
Adroll
adroll